The urinary and prostatic microbiome in non‐neurogenic male LUTS/BPH: A systematic review
Neurourology and Urodynamics · 2024
DOI: 10.1002/nau.25530 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Neurourology and Urodynamics, 2024. Verfasst von Teresa Pina-Vaz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Centro Hospitalar de São João, Porto, Portugal. Hauptthemen laut MEDLINE: Dysbiosis, Lower Urinary Tract Symptoms, Microbiota, Prostate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Introduction
Despite advancements in the treatment of benign prostatic hyperplasia (BPH), the mechanisms underlying BPH development and progression remain elusive and lacks a one‐size‐fits‐all therapeutic solution. Prostatic inflammation contributes to BPH and lower urinary tract symptoms (LUTS), but the initial trigger remains unknown. Current research suggests dysbiosis of the urinary microbiome as a potential culprit. This systematic review explores the emerging field of the male urinary and prostatic microbiome and its relationship with BPH/LUTS.
Methods
The Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines were followed. A systematic search in the Pubmed and Scopus databases was performed using specific terms. Inclusion criteria considered male non‐neurogenic patients with LUTS due to BPH with analyses of urinary microbiome, concerning evaluation of English‐language publications with relevance.
Results
Among seven articles involving 542 patients, there was an association between male LUTS/BPH and the urinary microbiome. Findings indicate a correlation between urinary microbiome dysbiosis and LUTS severity, with specific bacterial genera such as Streptococcus and Haemophilus linked to higher International Prostate Symptom Score (IPSS) scores and PSA levels. The fecal microbiome may be associated with LUTS, although contradictory findings are reported. The review also highlights methodological inconsistencies, small sample sizes, few negative controls and a lack of comprehensive clinical data as major limitations.
Conclusions
While there is an undeniable correlation between the microbiome and LUTS/BPH, future research should aim to standardize sampling techniques and expand the score to include functional microbiome characterization, potentially leading to novel, microbiome‐targeted therapeutic strategies for BPH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Centro Hospitalar de São João, Porto, Portugal.
- Department of Physiology and Surgery, Faculty of Medicine of University of Porto, Porto, Portugal.
- Department of Surgery and Physiology, Cardiovascular R&D Centre, UnIC@RISE, Porto, Portugal.
- Center for Health Technology and Services Research-CINTESIS@RISE, Faculty of Medicine, University of Porto, Porto, Portugal.
- I3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
Zitieren
APA
Pina-Vaz, T., Silva, A. C., Silva, C., Miranda, I., Cruz, F., & Silva, J. A. (2024). The urinary and prostatic microbiome in non‐neurogenic male LUTS/BPH: A systematic review. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25530
Vancouver
Pina-Vaz T, Silva AC, Silva C, Miranda I, Cruz F, Silva JA. The urinary and prostatic microbiome in non‐neurogenic male LUTS/BPH: A systematic review. Neurourology and Urodynamics. 2024. doi:10.1002/nau.25530
BibTeX
@article{PinaVaz2024,
author = {Pina-Vaz, Teresa and Silva, Alberto C and Silva, Carlos and Miranda, Isabel and Cruz, Francisco and Silva, João A},
title = {The urinary and prostatic microbiome in non‐neurogenic male LUTS/BPH: A systematic review},
journal = {Neurourology and Urodynamics},
year = {2024},
doi = {10.1002/nau.25530}
}
EUVIMED